Clinical trial
Visual Function as a Novel Outcome Measure Following Neonatal Hypoxic Ischemic Encephalopathy
NCT05971446 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Visual Function as a Novel Outcome Measure Following Neonatal Hypoxic Ischemic Encephalopathy
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 24, 2020
- Completion date
- July 31, 2029
- Enrollment
- 125 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
encephalopathy, hypoxic-ischemic encephalopathy, neonatal encephalopathy